Triazolam is a pharmaceutical raw material used as an active pharmaceutical ingredient in the manufacturing of sedative-hypnotic medications. It has a complex ring-containing structure and is associated with developmental toxicity according to government labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 28911-01-5
Alprazolam
pharmaceutical raw material
Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate
pharmaceutical raw material
Delorazepam
pharmaceutical raw material
Apalutamide Di-(2-fluoro-N-methylbenzamide)
pharmaceutical raw material
Canertinib dihydrochloride
pharmaceutical raw material
[8-Chloro-6-(2-chlorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl]methanol
research compound
8-Chloro-6-(2-chlorophenyl)-1-ethenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
pharmaceutical raw material
8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol
pharmaceutical intermediate or research reagent
8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
JOFWLTCLBGQGBO-UHFFFAOYSA-N
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl